Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Focal launches FocalSeal through Ethicon:

This article was originally published in Clinica

Executive Summary

Focal is to launch its FocalSeal surgical sealant in New Zealand, Australia, Hong Kong and South Africa, through Johnson & Johnson subsidiary Ethicon. Lexington, Massachusetts-based Focal's product will be marketed and distributed under the brandname Advaseal. The product is a synthetic, absorbable liquid sealant which is designed to prevent air leaks during lung surgery. Visible light from a specially-designed light source transforms the liquid into a tissue-adherent gel which creates a leak-proof seal over the wound.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT078470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel